Article Title,Year,Volume,Issue,Page Range,Author
Public-private arrangements in disaster relief and recovery,2005,27,9,1464-1466,Lyles
Drugs and falls in community-dwelling older people: a national veterans study,2006,28,4,619-630,Campbell
A single-center randomized double-blind placebo-controlled crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol with hydroxyzine hydrochloride 50 mg as a positive internal control on aspects of cognitive,2003,25,5,1518-1538,Johnson
Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization suicide and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study,2006,28,11,1912-1921,Ward
Systematic reviews of assessment measures and pharmacologic treatments for agitation,2010,32,3,403-425,Zeller
Sedative effects of antihistamines: safety performance learning and quality of life,1998,20,2,365-372,Donnelly
Safety profile of over-the-counter naproxen sodium,1995,17,4,587-601; discussion 586,DeArmond
Sedative effects of antihistamines: safety performance learning and quality of life,1997,19,1,39-55; discussion 2-3,Nolen
A multicenter randomized double-blind comparison of roxatidine with ranitidine in the treatment of patients with uncomplicated benign gastric ulcer disease. The Multicenter Roxatidine Cooperative Study Group,1995,17,3,467-478,Bender
Efficacy and safety of risperidone in the long-term treatment of patients with schizophrenia,1995,17,3,402-412,Eriksson
ICI 204636 a novel atypical antipsychotic: early indication of safety and efficacy in patients with chronic and subchronic schizophrenia,1995,17,3,366-378,Malick
The impact of race and fractures on mortality in a postmenopausal Medicaid population,1999,21,11,1988-2000,Martin
Illegal "no prescription" internet access to narrow therapeutic index drugs,2013,35,5,694-700,Liang
Zopiclone's residual effects on actual driving performance in a standardized test: a pooled analysis of age and sex effects in 4 placebo-controlled studies,2014,36,1,141-150,Leufkens
Are selective serotonin reuptake inhibitors safe for drivers? What is the evidence?,2012,34,5,1070-1083,Ramaekers
Prevalence cumulative incidence monotherapy and combination therapy and treatment duration of frequently prescribed psychoactive medications in the Netherlands: retrospective database analysis for the years 2000 to 2005,2010,32,14,2457-2466,De Gier
Selective Serotonin Reuptake Inhibitors Versus Tricyclic Antidepressants in Young Patients: A Meta-analysis of Efficacy and Acceptability,2014,36,7,1087-1095.e4,Qin
A retrospective pooled suicidality evaluation of ropinirole immediate release and controlled release for the treatment of restless legs syndrome,2015,37,5,1122-1127,Makumi
Changing the management of paracetamol poisoning,2015,37,9,2135-2141,Bateman
Impact of prolonged-release oxycodone/naloxone on outcomes affecting patients' daily functioning in comparison with extended-release tapentadol: a systematic review,2015,37,1,212-224,Thakur
Outpatient use of antidepressants and the incidence of suicide in Montenegro 2000-2015: are we going in optimistic direction?,2016,38,10S,e28-e29,Duborija-Kovacevic
Sleep and suicide in older adults: an opportunity for intervention,2016,38,11,2332-2339,Pigeon
Review of safety and efficacy of sleep medicines in older adults,2016,38,11,2340-2372,Ford
Dropout prevalence and associated factors in randomized clinical trials of adolescents treated for depression: systematic review and meta-analysis,2017,39,5,971-992.e4,Ferigolo
Gender differences in pain experience and treatment after motor vehicle collisions: a secondary analysis of the CRASH Injury Study,2018,40,2,204-213.e2,Peak
Sex differences in poisonings among older adults: an analysis of the Toxicology Investigators Consortium (ToxIC) Registry 2010 to 2016,2018,40,8,1366-1374.e8,Katz
Falls frailty vision and aging,2019,41,3,369-372,Shader
The impact of the opioid epidemic on children and adolescents,2019,ePub,ePub,ePub,Winstanley
The psychiatric consequences of cannabinoids,2018,40,9,1448-1456,Radhakrishnan
Psychological stress-induced immune response and risk of Alzheimer's disease in veterans from Operation Enduring Freedom and Operation Iraqi Freedom,2020,ePub,ePub,ePub,Kempuraj
Nine insights from 10 years of legal cannabis for nonmedical purposes,2023,45,6,496-505,Kilmer
A research agenda to inform cannabis regulation: how science can shape policy,2023,45,6,506-514,Schauer
Let's match: making cannabis policy guided by research,2023,45,6,515-520,Baker
History of cannabis regulation and medicinal therapeutics: it's complicated,2023,45,6,521-526,Johnson
The impact of cannabis use on adolescent neurodevelopment and clinical outcomes amidst changing state policies,2023,45,6,535-540,Levy
Cannabis policy in the 21st century: mandating an equitable future and shedding the racist past,2023,45,6,541-550,Allen
Cannabis social clubs in contemporary legalization reforms: talking consumption sites and social justice,2023,45,6,551-559,Wilkins
Risk factors for adolescent cannabis use in a state with legal recreational cannabis: the role of parents siblings and friends,2023,45,6,589-598,Whitehill
Exploring the impact of adult-use cannabis legalization on legal system referrals to treatment for cannabis use: do age and race have a moderating effect?,2023,45,6,599-615,Harris
Cannabis retail market indicators in five legal states in the United States: a public health perspective,2023,ePub,ePub,ePub,Kilmer
Emerging issues in cannabis law: big business and equity challenges,2023,45,7,679-683,Stoa
A meta-analysis of the efficacy and tolerability of interferon-β in multiple sclerosis overall and by drug and disease type,2010,32,11,1871-1888,Abdollahi
A Phase III Randomized Placebo-controlled Trial to Assess the Efficacy and Safety of Once-daily SPN-812 (Viloxazine Extended-release) in the Treatment of Attention-deficit/Hyperactivity Disorder in School-age Children,2020,42,8,1452-1466,Findling